BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 28423924)

  • 21. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
    Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
    Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
    De Paula D; Bentley MV; Mahato RI
    RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.
    Mishra DK; Balekar N; Mishra PK
    Drug Deliv Transl Res; 2017 Apr; 7(2):346-358. PubMed ID: 28050890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SiRNA delivery: challenges and role of carrier systems.
    Shegokar R; Al Shaal L; Mishra PR
    Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial siRNA Polyplexes for Receptor Targeting.
    Lee DJ; Wagner E
    Methods Mol Biol; 2019; 1974():83-98. PubMed ID: 31098997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric carrier systems for siRNA delivery.
    Vader P; van der Aa LJ; Storm G; Schiffelers RM; Engbersen JF
    Curr Top Med Chem; 2012; 12(2):108-19. PubMed ID: 22196278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the current status of siRNA nanomedicines in the treatment of cancer.
    Resnier P; Montier T; Mathieu V; Benoit JP; Passirani C
    Biomaterials; 2013 Sep; 34(27):6429-43. PubMed ID: 23727262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chitosan-siRNA complex nanoparticles for gene silencing].
    Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery and biodistribution of siRNA for cancer therapy: challenges and future prospects.
    Seth S; Johns R; Templin MV
    Ther Deliv; 2012 Feb; 3(2):245-61. PubMed ID: 22834200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix systems for siRNA delivery.
    Naeye B; Raemdonck K; Remaut K; Demeester J; De Smedt SC
    Curr Top Med Chem; 2012; 12(2):89-96. PubMed ID: 22196275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. siRNA delivery with lipid-based systems: promises and pitfalls.
    Foged C
    Curr Top Med Chem; 2012; 12(2):97-107. PubMed ID: 22196274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. siRNA-Based Drug Targeting Human Bcl-xL Against Cancers.
    Takei Y
    Methods Mol Biol; 2019; 1974():31-40. PubMed ID: 31098993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology.
    Ebrahimi N; Manavi MS; Nazari A; Momayezi A; Faghihkhorasani F; Rasool Riyadh Abdulwahid AH; Rezaei-Tazangi F; Kavei M; Rezaei R; Mobarak H; Aref AR; Fang W
    Environ Res; 2023 Dec; 239(Pt 2):117263. PubMed ID: 37797672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.